Wealthcare Advisory Partners’s MetLife MET Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $622K | Sell |
7,352
-1,888
| -20% | -$152K | 0.01% | 649 |
|
|
2026
Q1 | $653K | Buy |
9,240
+3,418
| +59% | +$256K | 0.01% | 624 |
|
|
2025
Q4 | $460K | Buy |
5,822
+78
| +1% | +$6.17K | 0.01% | 718 |
|
|
2025
Q3 | $473K | Sell |
5,744
-15
| -0.3% | -$1.18K | 0.01% | 696 |
|
|
2025
Q2 | $463K | Buy |
5,759
+370
| +7% | +$28.6K | 0.01% | 660 |
|
|
2025
Q1 | $433K | Sell |
5,389
-531
| -9% | -$44.2K | 0.01% | 620 |
|
|
2024
Q4 | $485K | Sell |
5,920
-3,001
| -34% | -$250K | 0.01% | 573 |
|
|
2024
Q3 | $736K | Sell |
8,921
-3,277
| -27% | -$245K | 0.02% | 483 |
|
|
2024
Q2 | $856K | Buy |
12,198
+391
| +3% | +$27.9K | 0.03% | 427 |
|
|
2024
Q1 | $875K | Buy |
11,807
+280
| +2% | +$19.5K | 0.03% | 404 |
|
|
2023
Q4 | $762K | Buy |
11,527
+565
| +5% | +$35.4K | 0.03% | 388 |
|
|
2023
Q3 | $690K | Sell |
10,962
-91
| -0.8% | -$5.67K | 0.03% | 357 |
|
|
2023
Q2 | $625K | Sell |
11,053
-2,228
| -17% | -$124K | 0.03% | 395 |
|
|
2023
Q1 | $769K | Buy |
13,281
+461
| +4% | +$31.1K | 0.03% | 347 |
|
|
2022
Q4 | $928K | Buy |
12,820
+617
| +5% | +$44.2K | 0.04% | 290 |
|
|
2022
Q3 | $742K | Buy |
12,203
+501
| +4% | +$32K | 0.04% | 280 |
|
|
2022
Q2 | $735K | Buy |
+11,702
| New | +$775K | 0.04% | 249 |
|
|
2021
Q2 | – | Sell |
-1,303
| Closed | -$79K | – | 1319 |
|
|
2021
Q1 | $79K | Buy |
+1,303
| New | +$71.9K | 0.01% | 738 |
|
|
2020
Q2 | – | Sell |
-371
| Closed | -$11K | – | 943 |
|
|
2020
Q1 | $11K | Sell |
371
-134
| -27% | -$5.94K | ﹤0.01% | 902 |
|
|
2019
Q4 | $26K | Sell |
505
-362
| -42% | -$17.5K | ﹤0.01% | 691 |
|
|
2019
Q3 | $41K | Sell |
867
-85
| -9% | -$4.05K | 0.01% | 578 |
|
|
2019
Q2 | $47K | Buy |
952
+629
| +195% | +$29.6K | 0.01% | 520 |
|
|
2019
Q1 | $14K | Buy |
323
+3
| +0.9% | +$133 | ﹤0.01% | 739 |
|
|
2018
Q4 | $13K | Sell |
320
-210
| -40% | -$9.01K | ﹤0.01% | 729 |
|
|
2018
Q3 | $25K | Sell |
530
-115
| -18% | -$5.25K | ﹤0.01% | 619 |
|
|
2018
Q2 | $28K | Sell |
645
-49
| -7% | -$2.28K | 0.01% | 588 |
|
|
2018
Q1 | $32K | Sell |
694
-28
| -4% | -$1.36K | 0.01% | 483 |
|
|
2017
Q4 | $36K | Buy |
722
+275
| +62% | +$14.5K | 0.01% | 431 |
|
|
2017
Q3 | $23K | Buy |
447
+446
| +44,600% | +$21.7K | 0.01% | 408 |
|
|
2017
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 123 |
|
|
2017
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 127 |
|
|
2016
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 117 |
|
|
2016
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 112 |
|
|
2016
Q2 | $0 | Buy |
+1
| New | +$39 | ﹤0.01% | 124 |
|
Other funds holding MET
AAMU
WCM
AV
FMII
P
FHC
FVWA
II
OIAM
Wealthcare Advisory Partners's MET Position: Q2 2026 in Review
Wealthcare Advisory Partners reduced its MetLife (MET) stake by 20% in Q2 2026, selling an estimated $152K and leaving 7,352 shares worth $622K. The position accounts for 0.01% of the portfolio, ranked #649.
Wealthcare Advisory Partners first reported a position in MET in Q2 2016 and has held it in 34 quarters since. The position peaked at $928K in Q4 2022. 330 funds tracked by Wall St. Rank hold MET as of Q2 2026.
- Wealthcare Advisory Partners held 7,352 shares of MetLife worth $622K as of Q2 2026.
- Wealthcare Advisory Partners sold 1,888 MetLife shares in Q2 2026, an estimated $152K.
- MetLife made up 0.01% of Wealthcare Advisory Partners's portfolio in Q2 2026, its #649 holding.
- Wealthcare Advisory Partners first reported a position in MetLife in Q2 2016 and has held it in 34 quarters since.
- Wealthcare Advisory Partners's MetLife position peaked at $928K in Q4 2022.
- 330 funds tracked by Wall St. Rank held MetLife as of Q2 2026.
Based on Wealthcare Advisory Partners's 13F filing for Q2 2026, filed 9 Jul 2026.